Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00328497 · ClinicalTrials.gov registry record · Phase 2

A Combination Study to Determine the Safety and Efficacy of Panzem NCD With Avastin in Metastatic Carcinoid Tumors

A Phase 2 study of Carcinoid Tumor, sponsored by CASI Pharmaceuticals.

Completed
Registry status
Phase 2
Development phase
31
Enrollment target
1
Study location

NCT00328497 is a Phase 2 study of Carcinoid Tumor that has completed, run by CASI Pharmaceuticals. The registered enrollment target is 31 participants, below the 95-participant average among 8 other Carcinoid Tumor trials with a reported enrollment target (67% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00328497, a Phase 2 study of Carcinoid Tumor, has completed, sponsored by CASI Pharmaceuticals.

COMPLETED
Registry status
Phase 2
Development phase
31 participants
Enrollment target
1
Study location

Study Summary

This single center, open-label study will evaluate the safety and efficacy of Panzem (2-methoxyestradiol, 2ME2) Nanocrystal Dispersion (NCD) administered orally with recombinant human monoclonal antibody against vascular endothelial growth factor (bevacizumab) administered intravenously, in patients with locally advanced or metastatic carcinoid tumors.

Conditions Studied

Carcinoid Tumor

Interventions

  • DRUG Panzem (2-methoxyestradiol) NCD, Avastin (Bevacizumab)

Study Locations (1)

Massachusetts

  • Dana-Farber Cancer Institute - Boston

Trial Details

FieldValue
Enrollment Target 31 participants
Start Date 2006-05
Est. Completion 2009-12
Phase Phase 2

Sponsor

CASI Pharmaceuticals

6 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00328497

The ClinicalTrials.gov registry entry for NCT00328497 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 31 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 95-participant average among 8 other Carcinoid Tumor trials with a reported enrollment target (67% lower). The listed sponsor is CASI Pharmaceuticals, which has 6 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Carcinoid Tumor appearing as the primary indexed condition, and to 1 intervention - of which Panzem (2-methoxyestradiol) NCD, Avastin (Bevacizumab) is the first listed.

NCT00328497 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT00328497 about?

NCT00328497 is a clinical study titled "A Combination Study to Determine the Safety and Efficacy of Panzem NCD With Avastin in Metastatic Carcinoid Tumors". This single center, open-label study will evaluate the safety and efficacy of Panzem (2-methoxyestradiol, 2ME2) Nanocrystal Dispersion (NCD) administered orally with recombinant human monoclonal antibody against vascular endothelial growth factor (bevacizumab) administered intravenously, in patients...

What is the current status of trial NCT00328497?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 31 participants. The study started on 2006-05. Estimated completion is 2009-12.

What conditions does trial NCT00328497 study?

This clinical trial studies the following conditions: Carcinoid Tumor.

What interventions are being tested in trial NCT00328497?

The interventions under investigation include: Panzem (2-methoxyestradiol) NCD, Avastin (Bevacizumab) (DRUG).

Who is sponsoring clinical trial NCT00328497?

This trial is sponsored by CASI Pharmaceuticals, which has 6 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00328497 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Carcinoid Tumor

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Carcinoid Tumor

All registered trials for this condition

Massachusetts

All trials with a study site in Massachusetts

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.